Annual EBIT
$3.27 B
-$32.70 B-90.92%
31 December 2023
Summary:
Pfizer annual earnings before interest & taxes is currently $3.27 billion, with the most recent change of -$32.70 billion (-90.92%) on 31 December 2023. During the last 3 years, it has fallen by -$5.22 billion (-61.50%). PFE annual EBIT is now -90.92% below its all-time high of $41.03 billion.PFE EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
$5.50 B
+$4.82 B+714.52%
30 September 2024
Summary:
Pfizer quarterly earnings before interest & taxes is currently $5.50 billion, with the most recent change of +$4.82 billion (+714.52%) on 30 September 2024. Over the past year, it has increased by +$8.15 billion (+306.93%). PFE quarterly EBIT is now -53.17% below its all-time high of $11.74 billion, reached on 01 June 2022.PFE Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
$6.94 B
+$8.15 B+672.85%
30 September 2024
Summary:
Pfizer TTM earnings before interest & taxes is currently $6.94 billion, with the most recent change of +$8.15 billion (+672.85%) on 30 September 2024. Over the past year, it has dropped by -$5.31 billion (-43.33%). PFE TTM EBIT is now -80.70% below its all-time high of $35.97 billion, reached on 31 December 2022.PFE TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PFE EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -90.9% | +306.9% | -43.3% |
| 3 y3 years | -61.5% | -32.7% | -69.0% |
| 5 y5 years | -33.5% | -50.6% | -39.5% |
PFE EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -90.9% | at low | -53.2% | +259.8% | -80.7% | +672.9% |
| 5 y | 5 years | -90.9% | at low | -53.2% | +173.8% | -80.7% | +672.9% |
| alltime | all time | -90.9% | +292.0% | -53.2% | +162.0% | -80.7% | +393.4% |
Pfizer EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $5.50 B(+714.5%) | $6.94 B(-672.9%) |
| June 2024 | - | $675.00 M(-84.0%) | -$1.21 B(-236.2%) |
| Mar 2024 | - | $4.21 B(-222.4%) | $890.00 M(-72.8%) |
| Dec 2023 | $3.27 B(-90.9%) | -$3.44 B(+29.5%) | $3.27 B(-73.3%) |
| Sept 2023 | - | -$2.66 B(-195.7%) | $12.25 B(-49.4%) |
| June 2023 | - | $2.78 B(-57.8%) | $24.22 B(-27.0%) |
| Mar 2023 | - | $6.59 B(+18.8%) | $33.18 B(-7.7%) |
| Dec 2022 | $35.97 B(+40.5%) | $5.54 B(-40.5%) | $35.97 B(+4.1%) |
| Sept 2022 | - | $9.31 B(-20.7%) | $34.57 B(+3.4%) |
| June 2022 | - | $11.74 B(+25.3%) | $33.42 B(+15.5%) |
| Mar 2022 | - | $9.37 B(+126.2%) | $28.95 B(+13.1%) |
| Dec 2021 | $25.60 B(+201.7%) | $4.14 B(-49.3%) | $25.60 B(+14.3%) |
| Sept 2021 | - | $8.17 B(+12.4%) | $22.41 B(+47.9%) |
| June 2021 | - | $7.26 B(+20.5%) | $15.15 B(+34.3%) |
| Mar 2021 | - | $6.03 B(+537.9%) | $11.28 B(+33.0%) |
| Dec 2020 | $8.48 B(-34.2%) | $945.00 M(+3.3%) | $8.48 B(+9766.3%) |
| Sept 2020 | - | $915.00 M(-73.0%) | $86.00 M(-99.2%) |
| June 2020 | - | $3.39 B(+5.0%) | $10.31 B(-9.9%) |
| Mar 2020 | - | $3.23 B(-143.4%) | $11.44 B(-11.3%) |
| Dec 2019 | $12.89 B(+162.6%) | -$7.45 B(-166.9%) | $12.90 B(+12.3%) |
| Sept 2019 | - | $11.14 B(+145.8%) | $11.48 B(+137.5%) |
| June 2019 | - | $4.53 B(-3.3%) | $4.83 B(-6.3%) |
| Mar 2019 | - | $4.68 B(-152.8%) | $5.16 B(+5.0%) |
| Dec 2018 | $4.91 B(-63.8%) | -$8.87 B(-297.6%) | $4.91 B(-67.4%) |
| Sept 2018 | - | $4.49 B(-7.5%) | $15.06 B(+4.0%) |
| June 2018 | - | $4.85 B(+9.4%) | $14.48 B(+5.3%) |
| Mar 2018 | - | $4.44 B(+245.6%) | $13.75 B(+1.3%) |
| Dec 2017 | $13.57 B(+42.3%) | $1.28 B(-67.1%) | $13.58 B(+1.6%) |
| Sept 2017 | - | $3.90 B(-5.4%) | $13.37 B(+17.7%) |
| June 2017 | - | $4.13 B(-3.1%) | $11.36 B(+14.4%) |
| Mar 2017 | - | $4.26 B(+297.0%) | $9.93 B(+4.1%) |
| Dec 2016 | $9.54 B(-6.2%) | $1.07 B(-43.4%) | $9.54 B(+12.9%) |
| Sept 2016 | - | $1.90 B(-29.9%) | $8.45 B(-11.3%) |
| June 2016 | - | $2.70 B(-30.1%) | $9.53 B(-10.5%) |
| Mar 2016 | - | $3.87 B(<-9900.0%) | $10.64 B(+4.7%) |
| Dec 2015 | $10.16 B(-25.3%) | -$19.00 M(-100.6%) | $10.16 B(-17.6%) |
| Sept 2015 | - | $2.98 B(-22.1%) | $12.34 B(-7.2%) |
| June 2015 | - | $3.82 B(+12.6%) | $13.29 B(-3.8%) |
| Mar 2015 | - | $3.39 B(+57.3%) | $13.82 B(+1.6%) |
| Dec 2014 | $13.60 B(-20.6%) | $2.16 B(-45.1%) | $13.60 B(-8.4%) |
| Sept 2014 | - | $3.93 B(-9.6%) | $14.85 B(+0.1%) |
| June 2014 | - | $4.35 B(+37.2%) | $14.84 B(-8.4%) |
| Mar 2014 | - | $3.17 B(-7.0%) | $16.20 B(-5.4%) |
| Dec 2013 | $17.13 B(+34.2%) | $3.41 B(-12.9%) | $17.13 B(+5.9%) |
| Sept 2013 | - | $3.91 B(-31.5%) | $16.17 B(+4.7%) |
| June 2013 | - | $5.71 B(+39.5%) | $15.45 B(+8.1%) |
| Mar 2013 | - | $4.10 B(+67.2%) | $14.29 B(+9.8%) |
| Dec 2012 | $12.76 B(-3.0%) | $2.45 B(-23.1%) | $13.02 B(+5.9%) |
| Sept 2012 | - | $3.19 B(-30.1%) | $12.30 B(-5.9%) |
| June 2012 | - | $4.56 B(+61.3%) | $13.07 B(+5.4%) |
| Mar 2012 | - | $2.83 B(+63.5%) | $12.40 B(-5.7%) |
| Dec 2011 | $13.16 B(+16.8%) | $1.73 B(-56.4%) | $13.15 B(+2.2%) |
| Sept 2011 | - | $3.96 B(+2.0%) | $12.87 B(+19.8%) |
| June 2011 | - | $3.88 B(+8.6%) | $10.74 B(-3.8%) |
| Mar 2011 | - | $3.58 B(+148.2%) | $11.17 B(-0.8%) |
| Dec 2010 | $11.27 B(-6.6%) | $1.44 B(-21.7%) | $11.27 B(+9.5%) |
| Sept 2010 | - | $1.84 B(-57.3%) | $10.29 B(-19.5%) |
| June 2010 | - | $4.32 B(+17.5%) | $12.79 B(+6.1%) |
| Mar 2010 | - | $3.67 B(+684.4%) | $12.06 B(-5.4%) |
| Dec 2009 | $12.06 B(+18.1%) | $468.00 M(-89.2%) | $12.74 B(+10.7%) |
| Sept 2009 | - | $4.34 B(+21.2%) | $11.52 B(+4.7%) |
| June 2009 | - | $3.58 B(-17.8%) | $11.00 B(+3.7%) |
| Mar 2009 | - | $4.36 B(-673.3%) | $10.61 B(+5.5%) |
| Dec 2008 | $10.21 B(-1.2%) | -$760.00 M(-119.9%) | $10.05 B(-24.9%) |
| Sept 2008 | - | $3.82 B(+19.7%) | $13.39 B(+28.8%) |
| June 2008 | - | $3.19 B(-16.0%) | $10.40 B(+10.7%) |
| Mar 2008 | - | $3.80 B(+47.5%) | $9.39 B(-9.2%) |
| Dec 2007 | $10.34 B(-27.6%) | $2.58 B(+210.0%) | $10.34 B(-0.2%) |
| Sept 2007 | - | $831.00 M(-61.9%) | $10.36 B(-22.7%) |
| June 2007 | - | $2.18 B(-54.0%) | $13.39 B(-9.0%) |
| Mar 2007 | - | $4.75 B(+82.7%) | $14.71 B(+3.0%) |
| Dec 2006 | $14.28 B(+0.5%) | $2.60 B(-32.8%) | $14.28 B(-5.4%) |
| Sept 2006 | - | $3.87 B(+10.3%) | $15.10 B(+2.1%) |
| June 2006 | - | $3.50 B(-18.7%) | $14.78 B(+1.8%) |
| Mar 2006 | - | $4.31 B(+26.4%) | $14.52 B(+1.0%) |
| Dec 2005 | $14.21 B(-13.5%) | $3.41 B(-4.0%) | $14.37 B(-4.6%) |
| Sept 2005 | - | $3.55 B(+9.8%) | $15.06 B(-5.5%) |
| June 2005 | - | $3.24 B(-22.3%) | $15.93 B(-2.3%) |
| Mar 2005 | - | $4.17 B(+1.7%) | $16.31 B(-0.7%) |
| Dec 2004 | $16.43 B | $4.10 B(-7.3%) | $16.43 B(+9.4%) |
| Sept 2004 | - | $4.42 B(+22.4%) | $15.01 B(+13.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2004 | - | $3.62 B(-15.7%) | $13.17 B(+15.3%) |
| Mar 2004 | - | $4.29 B(+59.9%) | $11.42 B(+7.5%) |
| Dec 2003 | $10.37 B(-15.2%) | $2.68 B(+3.7%) | $10.63 B(-8.0%) |
| Sept 2003 | - | $2.59 B(+38.6%) | $11.55 B(-4.0%) |
| June 2003 | - | $1.87 B(-46.6%) | $12.03 B(-4.8%) |
| Mar 2003 | - | $3.49 B(-3.0%) | $12.64 B(+3.4%) |
| Dec 2002 | $12.22 B(+15.1%) | $3.60 B(+17.5%) | $12.22 B(+10.7%) |
| Sept 2002 | - | $3.06 B(+23.8%) | $11.04 B(+2.1%) |
| June 2002 | - | $2.48 B(-19.5%) | $10.81 B(-1.0%) |
| Mar 2002 | - | $3.08 B(+27.2%) | $10.92 B(+2.7%) |
| Dec 2001 | $10.61 B(+23.9%) | $2.42 B(-14.8%) | $10.63 B(+0.6%) |
| Sept 2001 | - | $2.84 B(+9.8%) | $10.56 B(+6.0%) |
| June 2001 | - | $2.59 B(-7.2%) | $9.96 B(+7.7%) |
| Mar 2001 | - | $2.79 B(+18.5%) | $9.25 B(+8.0%) |
| Dec 2000 | $8.57 B(+23.1%) | $2.35 B(+5.1%) | $8.57 B(+5.4%) |
| Sept 2000 | - | $2.24 B(+19.4%) | $8.13 B(+8.9%) |
| June 2000 | - | $1.87 B(-11.0%) | $7.47 B(+2.0%) |
| Mar 2000 | - | $2.11 B(+10.0%) | $7.32 B(+14.9%) |
| Dec 1999 | $6.96 B(+30.1%) | $1.91 B(+21.8%) | $6.37 B(-9.0%) |
| Sept 1999 | - | $1.57 B(-9.0%) | $7.00 B(+9.2%) |
| June 1999 | - | $1.73 B(+49.5%) | $6.41 B(+14.6%) |
| Mar 1999 | - | $1.16 B(-54.6%) | $5.59 B(+4.5%) |
| Dec 1998 | $5.35 B(+74.1%) | $2.54 B(+158.8%) | $5.35 B(+50.9%) |
| Sept 1998 | - | $983.00 M(+7.9%) | $3.54 B(+4.6%) |
| June 1998 | - | $911.00 M(-0.2%) | $3.39 B(+6.7%) |
| Mar 1998 | - | $913.00 M(+23.7%) | $3.17 B(-0.5%) |
| Dec 1997 | $3.07 B(+12.0%) | $738.00 M(-10.7%) | $3.19 B(+9.4%) |
| Sept 1997 | - | $826.00 M(+18.5%) | $2.92 B(-0.3%) |
| June 1997 | - | $697.00 M(-25.1%) | $2.93 B(+4.4%) |
| Mar 1997 | - | $930.00 M(+100.4%) | $2.80 B(+4.5%) |
| Dec 1996 | $2.74 B(+7.1%) | $464.00 M(-44.4%) | $2.68 B(-7.3%) |
| Sept 1996 | - | $835.00 M(+45.5%) | $2.89 B(+5.2%) |
| June 1996 | - | $574.00 M(-29.0%) | $2.75 B(+1.4%) |
| Mar 1996 | - | $809.00 M(+20.1%) | $2.71 B(+7.0%) |
| Dec 1995 | $2.56 B(+29.8%) | $673.80 M(-2.5%) | $2.53 B(+7.2%) |
| Sept 1995 | - | $691.40 M(+28.9%) | $2.36 B(+8.5%) |
| June 1995 | - | $536.40 M(-15.0%) | $2.18 B(+6.8%) |
| Mar 1995 | - | $630.90 M(+25.5%) | $2.04 B(+3.3%) |
| Dec 1994 | $1.97 B(+116.0%) | $502.90 M(-0.8%) | $1.97 B(+75.5%) |
| Sept 1994 | - | $506.90 M(+27.6%) | $1.12 B(+5.5%) |
| June 1994 | - | $397.20 M(-29.8%) | $1.07 B(-12.8%) |
| Mar 1994 | - | $565.50 M(-263.6%) | $1.22 B(+6.8%) |
| Dec 1993 | $913.30 M(-36.7%) | -$345.60 M(-177.1%) | $1.14 B(-38.1%) |
| Sept 1993 | - | $448.20 M(-19.1%) | $1.85 B(+2.5%) |
| June 1993 | - | $553.70 M(+13.5%) | $1.80 B(+18.3%) |
| Mar 1993 | - | $487.80 M(+36.6%) | $1.52 B(+5.5%) |
| Dec 1992 | $1.44 B(+15.1%) | $357.20 M(-11.4%) | $1.44 B(+7.2%) |
| Sept 1992 | - | $403.00 M(+46.9%) | $1.35 B(+2.2%) |
| June 1992 | - | $274.40 M(-32.9%) | $1.32 B(+2.2%) |
| Mar 1992 | - | $408.80 M(+56.7%) | $1.29 B(+2.9%) |
| Dec 1991 | $1.25 B(+19.0%) | $260.80 M(-30.2%) | $1.25 B(+4.2%) |
| Sept 1991 | - | $373.40 M(+51.4%) | $1.20 B(+3.9%) |
| June 1991 | - | $246.60 M(-33.8%) | $1.16 B(+3.3%) |
| Mar 1991 | - | $372.70 M(+77.0%) | $1.12 B(+6.4%) |
| Dec 1990 | $1.05 B(+8.8%) | $210.60 M(-35.9%) | $1.05 B(-144.5%) |
| Sept 1990 | - | $328.50 M(+57.0%) | -$2.37 B(+88.4%) |
| June 1990 | - | $209.30 M(-31.5%) | -$1.26 B(+672.0%) |
| Mar 1990 | - | $305.40 M(-109.5%) | -$162.70 M(-116.8%) |
| Dec 1989 | $968.20 M(-4.3%) | -$3.21 B(-323.1%) | $968.20 M(-17.4%) |
| Sept 1989 | - | $1.44 B(+10.4%) | $1.17 B(+5.0%) |
| June 1989 | - | $1.30 B(-9.3%) | $1.12 B(-2.9%) |
| Mar 1989 | - | $1.44 B(-147.8%) | $1.15 B(+13.7%) |
| Dec 1988 | $1.01 B(+7.6%) | -$3.01 B(-317.3%) | $1.01 B(-23.0%) |
| Sept 1988 | - | $1.38 B(+3.5%) | $1.31 B(+6.9%) |
| June 1988 | - | $1.34 B(+3.0%) | $1.23 B(+9.8%) |
| Mar 1988 | - | $1.30 B(-148.0%) | $1.12 B(+19.0%) |
| Dec 1987 | $940.80 M(-2.0%) | -$2.70 B(-308.3%) | $940.80 M(-27.1%) |
| Sept 1987 | - | $1.30 B(+5.8%) | $1.29 B(+11.7%) |
| June 1987 | - | $1.23 B(+9.6%) | $1.16 B(+10.4%) |
| Mar 1987 | - | $1.12 B(-147.6%) | $1.05 B(+9.1%) |
| Dec 1986 | $959.70 M(+9.1%) | -$2.35 B(-302.3%) | $959.70 M(-21.8%) |
| Sept 1986 | - | $1.16 B(+4.0%) | $1.23 B(+14.0%) |
| June 1986 | - | $1.12 B(+8.3%) | $1.08 B(+12.1%) |
| Mar 1986 | - | $1.03 B(-149.5%) | $960.20 M(+9.9%) |
| Dec 1985 | $880.00 M(+5.6%) | -$2.09 B(-306.0%) | $873.80 M(-3.5%) |
| Sept 1985 | - | $1.01 B(+1.1%) | $905.70 M(+3.4%) |
| June 1985 | - | $1.00 B(+5.9%) | $875.60 M(+1.9%) |
| Mar 1985 | - | $945.70 M(-146.0%) | $859.40 M(+3.1%) |
| Dec 1984 | $833.50 M | -$2.05 B(-309.1%) | $833.50 M(-71.1%) |
| Sept 1984 | - | $982.70 M(-0.3%) | $2.89 B(+51.6%) |
| June 1984 | - | $985.70 M(+7.2%) | $1.91 B(+107.2%) |
| Mar 1984 | - | $919.80 M | $919.80 M |
FAQ
- What is Pfizer annual earnings before interest & taxes?
- What is the all time high annual EBIT for Pfizer?
- What is Pfizer annual EBIT year-on-year change?
- What is Pfizer quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Pfizer?
- What is Pfizer quarterly EBIT year-on-year change?
- What is Pfizer TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Pfizer?
- What is Pfizer TTM EBIT year-on-year change?
What is Pfizer annual earnings before interest & taxes?
The current annual EBIT of PFE is $3.27 B
What is the all time high annual EBIT for Pfizer?
Pfizer all-time high annual earnings before interest & taxes is $41.03 B
What is Pfizer annual EBIT year-on-year change?
Over the past year, PFE annual earnings before interest & taxes has changed by -$32.70 B (-90.92%)
What is Pfizer quarterly earnings before interest & taxes?
The current quarterly EBIT of PFE is $5.50 B
What is the all time high quarterly EBIT for Pfizer?
Pfizer all-time high quarterly earnings before interest & taxes is $11.74 B
What is Pfizer quarterly EBIT year-on-year change?
Over the past year, PFE quarterly earnings before interest & taxes has changed by +$8.15 B (+306.93%)
What is Pfizer TTM earnings before interest & taxes?
The current TTM EBIT of PFE is $6.94 B
What is the all time high TTM EBIT for Pfizer?
Pfizer all-time high TTM earnings before interest & taxes is $35.97 B
What is Pfizer TTM EBIT year-on-year change?
Over the past year, PFE TTM earnings before interest & taxes has changed by -$5.31 B (-43.33%)